DYNT: Dynatronics Expected earnings per share growth for next year
Dynatronics Corporation (DYNT) relies on robust distribution channels within sports medicine, which supports the earnings per share forecast for the coming year on the GURU.Markets terminal chart. However, market fragmentation and the risk of reduced insurance payouts are squeezing margins, while asset sales are weakening the firm's position. Meanwhile, 0.00 represents the current value of the indicator.
Analytical breakdowns for Dynatronics (DYNT)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Dynatronics Corporation|DYNT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Dynatronics Corp|DYNT - Company Total Debt Obligations|Debts to Book Capitalization Dynatronics|DYNT - Company Long-Term Liabilities|Company Short-Term Debts Dynatronics|Quick Liquidity dynatronics.com
- net income and valuation ratios data:
DYNT - Company Net Income|Future Profit Dynatronics Corporation|DYNT - Company Value to Net Income|Forward P/E Multiple Dynatronics Corp|DYNT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics|DYNT - Operating profit before depreciation charges|Net earnings per share for the last 12 months Dynatronics|DYNT - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth dynatronics.com|DYNT - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Dynatronics Corporation
Initial company analysis:Dynatronics Corporation, DYNT
Professional capital evaluates Dynatronics Corporation (DYNT) through the lens of stable demand for medical innovations, rendering the asset a resilient defensive tool. Analyzing the forward-looking earnings per share growth forecast, the investor monitors the pace of analyst consensus revisions, where a reversal in net income expectations signals a shift in the market cycle and determines the issuer's fundamental attractiveness.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IART|Expected earnings per share growth for next year Establishment Labs Inc ESTA|Earnings growth forecast for next year BBNX (Beta Bionics Inc)|Earnings growth forecast for next year iradimed.com IRMD|EMBC - Net earnings per share growth forecast for next year|TNDM: Net earnings per share growth forecast for next year|AXGN (Axogen Corp) - Expected earnings per share growth for next year|SI-BONE Medical - Expected earnings per share trend next year|OFIX (Orthofix Medical Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year bioventus.com BVS|Net earnings per share growth forecast for next year OrthoPediatrics Corp. (KIDS)|Treace Medical Concepts Inc (TMCI) - Net earnings per one share growth forecast for next year|Strata Critical Medical Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year Carlsmed Medical CARL|RxSight, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year ClearPoint Neuro, Inc. CLPT|Stereotaxis (STXS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year STIM (Neuronetics Inc.)|Net earnings per share growth forecast for next year Sight Sciences, Inc|Expected earnings per share growth for next year Orchestra BioMed Inc. (OBIO)|Earnings growth forecast for next year ANIK|NSPR - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Jin Medical ZJYL|VANI: Projected earnings per share growth rate for next year|XTNT: Expected earnings per share growth for next year|NeuroOne Medical Technologies Corp. - Projected earnings per share increase next year|MODD: Earnings growth forecast for next year|Projected earnings per share growth rate for next year MYO|Expected earnings per share growth for next year COCH|Expected net earnings per share growth next year Vivos Therapeutics Inc. VVOS|Net earnings per share growth forecast for next year enVVeno (NVNO)|sintx.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year TNON (Tenon Medical, Inc.)|Earnings growth forecast for next year rewalk.com LFWD|AMIX: Expected earnings per share growth for next year|INVO Bioscience - Projected earnings per share increase next year|Bone Biologics Corporation (BBLG) - Net earnings per share growth forecast for next year|Axonics, Inc - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BIOLASE, Inc.|Expected net earnings per share growth next year Paragon 28 Corp FNA|Net earnings per share growth forecast for next year INVO Bioscience, Inc. (INVO)
